Developing peptide-based fusion inhibitors as an antiviral strategy utilizing Coronin 1 as a template
Manbit Subhadarsi Panda, Bushra Qazi, Vaishali Vishwakarma, Gourab Prasad Pattnaik, Sourav Haldar, Hirak Chakraborty
This paper develops a peptide-based fusion inhibitor, mTG-23, derived from coronin 1, which inhibits membrane fusion in vitro and reduces influenza A virus infection in cell lines.
RSC Medicinal Chemistry · Oct 2, 2024Peer-reviewedBiophysics